Prevalence of Thrombocytopenia Amongst Patients with Cirrhosis Presenting to Shaheed Saif Ur Rehman Government Hospital, Gilgit
DOI:
https://doi.org/10.54112/bcsrj.v6i4.1595Keywords:
Thrombocytopenia, cirrhosis, frequencyAbstract
Thrombocytopenia is a common complication in patients with cirrhosis, often impacting clinical management. Understanding its frequency and associations can enhance early diagnosis and treatment strategies. Objective: To determine the frequency of thrombocytopenia among patients with cirrhosis and identify factors associated with its occurrence. Methods: A cross-sectional study was conducted after obtaining ethical approval from the Shaheed Saif-Ur-Rehman Government Teaching Hospital, Gilgit, and the CPSP (December 26, 2024, to March 26, 2025. The study included 190 patients who met the selection criteria, and written informed consent was obtained from each participant. Comprehensive physical and clinical examinations were performed, and a liver ultrasound was conducted to confirm cirrhosis. Blood samples were analyzed to assess platelet counts, with thrombocytopenia defined as a platelet count below 150,000 per cubic millimeter. A pre-designed proforma recorded demographic data, disease duration, and body mass index (BMI). Statistical analysis was performed using SPSS version 25. Results: The mean age of participants was 45.63±9.08 years, with 37.4% being above 50 years. Males represented 54.2% of the sample. The mean BMI was 26.87±3.56 kg/m², and the mean disease duration was 8.43±2.32 months. Urban residents comprised 60.0% of the sample. Monthly income distribution showed that 43.7% earned Rs. 40,000-80,000, and 35.8% earned less than Rs. 40,000. Most were from low socioeconomic backgrounds (52.1%), and 37.4% were illiterate. Thrombocytopenia was observed in 57.9% of patients, with a significant association found only with urban residence (p = 0.03). No significant associations were found with age, gender, income, or education. Conclusion: Thrombocytopenia is prevalent in more than half of cirrhotic patients, with a substantial association observed with urban residence. No significant links were found with age, gender, socioeconomic status, income, or education. Regular monitoring of platelet counts is crucial for the early detection and management of thrombocytopenia in cirrhotic patients. Further studies are needed to explore contributing factors and improve treatment strategies.
Downloads
References
Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Molecular aspects of medicine. 2019;65:37-55.
Moore AH. Thrombocytopenia in cirrhosis: a review of pathophysiology and management options. Clinical liver disease. 2019;14(5):183-6.
Kothari MK. A Study of Clinical and Laboratory Profile of Patients with Febrile Thrombocytopenia Admitted in Navodaya Medical College Hospital and Research Centre, Raichur: Rajiv Gandhi University of Health Sciences (India); 2017.
Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepatic medicine: evidence and research. 2016:39-50.
Zakeri N, Tsochatzis EA. Bleeding risk with invasive procedures in patients with cirrhosis and coagulopathy. Current Gastroenterology Reports. 2017;19:1-9.
Abbas M, Sardar J, Asim M, Khan R, Khan S, Jaffar G. Frequency of thrombocytopenia in patients with chronic liver diseases in tertiary care hospital. Pakistan Journal of Medical & Health Science. 2022;16:739-41.
Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Okugawa H, et al. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis. Scandinavian Journal of Gastroenterology. 2016;51(2):236-44.
Nilles KM, Flamm SL. Thrombocytopenia in chronic liver disease: new management strategies. Clinics in liver disease. 2020;24(3):437-51.
Lim HI, Cuker A. Thrombocytopenia and liver disease: pathophysiology and periprocedural management. Hematology. 2022;2022(1):296-302.
Peck‐Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver International. 2017;37(6):778-93.
Crickx E, Mahévas M, Michel M, Godeau B. Older adults and immune thrombocytopenia: considerations for the clinician. Clinical interventions in aging. 2023:115-30.
Andrès E, Mecili M, Fothergill H, Zimmer J, Vogel T, Maloisel F. Gender-related analysis of the clinical presentation, treatment response, and outcome in patients with immune thrombocytopenia. La Presse Médicale. 2012;41(9):e426-e31.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zohaira Rehman, Mahtab jan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.